The SCiRM program is directed by Dr. Stelios Andreadis and co-directed by Dr. Richard Gronostajski and Dr. Sriram Neelamegham.
Stelios Andreadis, PhD received his MS (Applied Mathematics) and PhD degree in Chemical Engineering from the University of Michigan in the dynamics of retroviral gene transfer for gene therapy. He then pursued postdoctoral training at the Center for Engineering in Medicine at Harvard Medical School, where he trained in the areas of gene therapy, tissue engineering and regenerative medicine. Currently he serves as the Director of the Stem Cells in Regenerative Medicine (SCiRM) Training Program, SUNY Distinguished Professor and Chair of Chemical and Biological Engineering, Professor of Biomedical Engineering and is a member of the UB Center of Excellence in Bioinformatics and Life Sciences.
Richard M. Gronostajski, PhD received his MS in Biochemistry from Virginia Tech for studies on cell cycle regulation in Chlorella. He received his PhD in Physiology from Harvard University on the role of intracellular protein turnover in cell cycle regulation. His postdoctoral studies were at Albert Einstein College of Medicine and the University of Toronto on viral and cellular DNA replication and mechanisms of the FLP recombinase, respectively. After positions at the University of Toronto, the Cleveland Clinic and Case Western Reserve University he joined UB in 2001 to work on the role of Nuclear Factor I transcription factors in animal development. He is a Professor of Biochemistry and currently serves as the Director of the Genetics, Genomics & Bioinformatics (GGB) Graduate Program and the WNYSTEM Stem Cell Facility, is on the steering committee for the Stem Cells in Regenerative Medicine (SCiRM) training program and is a member of the GEM (Genetics, Environment and Microbiome) community of excellence.
Sriram Neelamegham received his PhD degree in Chemical Engineering from Rice University, with specialization in Bioengineering. He subsequently performed biomedical research related to human immune cell adhesion biology and vascular biology at the Baylor College of Medicine. His current research interests lie at the intersection of Systems Biology with human Inflammation Research, Thrombosis and Regenerative Medicine. In particular, he is interested in studying the impact of glycosylation on disease processes and translational medicine. Prof. Neelamegham is a Professor of Chemical & Biological Engineering, Biomedical Engineering and Medicine. He serves on the steering committee of the Stem Cells in Regenerative Medicine (SCiRM) training program